What does CUSIP 872381108 represent in this 13F holders report?

CUSIP 872381108 is the security identifier for TELA - TELA Bio, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held TELA - TELA Bio, Inc. - Common Stock in Q4 2025?

41 institutional investors reported TELA - TELA Bio, Inc. - Common Stock for Q4 2025. Use the holders table for investor-level position and value details.

TELA Bio, Inc. - Common Stock (TELA)

CUSIP: 872381108

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class: Equity / Common Stock
Shares outstanding: 44,406,200
Total 13F shares: 27,581,886
Share change: +3,998,933
Total reported value: $32,498,316
Price per share: $1.18
Number of holders: 41
Value change: +$4,151,171
Number of buys: 18
Number of sells: 13

Quarterly Holders Quick Answers

What is CUSIP 872381108?
CUSIP 872381108 identifies TELA - TELA Bio, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2026
Previous quarter: Q3 2025

Recent filing periods for CUSIP 872381108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TELA - TELA Bio, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Opaleye Management Inc.	3/4/5	Former 10% Owner.	— class O/S missing	2,072,813	$11,710,150	—	20 Apr 2023	3/4/5
EW HEALTHCARE PARTNERS FUND 2, L.P.	13D/G 3/4/5	EW Healthcare Partners Fund 2 GP, L.P. · Other*, 10%+ Owner	17%	7,714,709	$11,572,064	$0	17 Nov 2025	13D/G 3/4/5
ORBIMED ADVISORS LLC	3/4/5	10%+ Owner	— class O/S missing	2,407,242	$10,928,879	—	28 Jun 2024	3/4/5
Nantahala Capital Management, LLC	13F 13D/G	Company	13% from 13D/G	5,111,588	$7,616,266	—	30 Sep 2025	13F 13D/G
Essex Woodlands Management, Inc.	13F	Company	9.3%	4,110,709	$6,124,956	—	30 Sep 2025	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F 13D/G	Company	7.8% from 13D/G	2,782,923	$4,146,555	—	30 Sep 2025	13F 13D/G
NORTH RUN CAPITAL, LP	13D/G	—	9.3%	3,682,489	$3,608,839	+$1,666,000	31 Mar 2025	13D/G
Stonepine Capital Management, LLC	13F 13D/G	Company	6% from 13D/G	2,155,519	$3,211,723	—	30 Sep 2025	13F 13D/G
VANGUARD GROUP INC	13F	Company	4.1%	1,799,884	$2,681,827	—	30 Sep 2025	13F
DAFNA Capital Management LLC	13F	Company	3.2%	1,441,029	$2,147,133	—	30 Sep 2025	13F
Orin Hirschman	13D/G	—	3.6%	1,416,323	$1,331,344	-$1,171,674	31 Mar 2025	13D/G
PERKINS CAPITAL MANAGEMENT INC	13F	Company	1.9%	833,928	$1,242,553	—	30 Sep 2025	13F
CITIGROUP INC	13F	Company	1.7%	750,000	$1,117,500	—	30 Sep 2025	13F
Velan Capital Investment Management LP	13F	Company	1.7%	747,410	$1,113,641	—	30 Sep 2025	13F
Pentwater Capital Management LP	13F	Company	1.6%	724,856	$1,080,035	—	30 Sep 2025	13F
Sio Capital Management, LLC	13F	Company	1.4%	636,300	$948,087	—	30 Sep 2025	13F
BlackRock, Inc.	13F	Company	1%	460,606	$686,304	—	30 Sep 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.8%	356,721	$531,581	—	30 Sep 2025	13F
WealthTrust Axiom LLC	13F	Company	0.52%	231,938	$345,587	—	30 Sep 2025	13F
UBS Group AG	13F	Company	0.49%	216,802	$323,035	—	30 Sep 2025	13F
PARADIGM CAPITAL MANAGEMENT INC/NY	13F	Company	0.45%	200,000	$298,000	—	30 Sep 2025	13F
Peter C. Murphy	3/4/5	Chief Commercial Officer	— mixed-class rows	67,429 mixed-class rows	$272,891	—	31 Mar 2024	3/4/5
NORTHERN TRUST CORP	13F	Company	0.39%	175,319	$261,225	—	30 Sep 2025	13F
Birchview Capital, LP	13F	Company	0.35%	155,000	$230,950	—	30 Sep 2025	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.24%	105,809	$158,000	—	30 Sep 2025	13F
Ellis Skott Greenhalgh	3/4/5	Chief Technology Officer	— mixed-class rows	34,501 mixed-class rows	$157,200	—	24 Feb 2022	3/4/5
UP STRATEGIC WEALTH INVESTMENT ADVISORS LLC	13F	Company	0.22%	99,888	$147,834	—	30 Sep 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.19%	85,763	$127,787	—	30 Sep 2025	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.14%	63,900	$95,211	—	30 Sep 2025	13F
STATE STREET CORP	13F	Company	0.14%	63,383	$94,441	—	30 Sep 2025	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.13%	57,500	$85,675	—	30 Sep 2025	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0.12%	53,612	$79,882	—	30 Sep 2025	13F
Destiny Wealth Partners, LLC	13F	Company	0.12%	52,500	$78,225	—	30 Sep 2025	13F
CITADEL ADVISORS LLC	13F	Company	0.08%	35,281	$52,569	—	30 Sep 2025	13F
John Nosenzo	3/4/5	Director	— mixed-class rows	11,630 mixed-class rows	$35,422	—	01 Jun 2023	3/4/5
RAYMOND JAMES FINANCIAL INC	13F	Company	0.05%	20,200	$30,098	—	30 Sep 2025	13F
Vincent J. Burgess	3/4/5	Director	— mixed-class rows	35,030 mixed-class rows	$22,863	—	28 May 2025	3/4/5
Embree Financial Group	13F	Company	0.03%	14,000	$20,860	—	30 Sep 2025	13F
Douglas G. Evans	3/4/5	Director	— mixed-class rows	30,170 mixed-class rows	$18,100	—	28 May 2025	3/4/5
Federica F. O'Brien	3/4/5	Director	— mixed-class rows	30,170 mixed-class rows	$18,100	—	28 May 2025	3/4/5
Kurt Azarbarzin	3/4/5	Director	— mixed-class rows	30,170 mixed-class rows	$18,100	—	28 May 2025	3/4/5
Lisa N. Colleran	3/4/5	Director	— mixed-class rows	30,170 mixed-class rows	$18,100	—	28 May 2025	3/4/5
Betty Jo Rocchio	3/4/5	Director	— mixed-class rows	29,475 mixed-class rows	$17,768	—	09 Oct 2025	3/4/5
William J. Plovanic	3/4/5	Director	— mixed-class rows	29,475 mixed-class rows	$17,768	—	31 Oct 2025	3/4/5
HighTower Advisors, LLC	13F	Company	0.02%	10,352	$15,424	—	30 Sep 2025	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	4,200	$6,258	—	30 Sep 2025	13F
MORGAN STANLEY	13F	Company	0%	2,219	$3,306	—	30 Sep 2025	13F
Steward Partners Investment Advisory, LLC	13F	Company	0%	1,991	$2,967	—	30 Sep 2025	13F
ROYAL BANK OF CANADA	13F	Company	0%	500	$1,000	—	30 Sep 2025	13F
CWM, LLC	13F	Company	0%	337	$1,000	—	30 Sep 2025	13F

Institutional Holders of TELA Bio, Inc. - Common Stock (TELA) as of Q4 2025

As of 31 Dec 2025, TELA Bio, Inc. - Common Stock (TELA) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,581,886 shares. The largest 10 holders included Essex Woodlands Management, Inc., Nantahala Capital Management, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, Stonepine Capital Management, LLC, VANGUARD GROUP INC, UBS Group AG, DAFNA Capital Management LLC, PERKINS CAPITAL MANAGEMENT INC, CITIGROUP INC, and Sio Capital Management, LLC. This page lists 41 institutional shareholders reporting positions in this security for the Q4 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders

Q4 2025 holders

Holder diff

Investor	Q3 2025 Shares	Q4 2025 Shares	Share Diff	Share Chg %	Q3 2025 Value $	Q4 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.